There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one […]
Orphan Drug Patents: Concerns Raised by Payers and Policy Makers Read Post »
A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge
Why Generic Drug Makers May Benefit from 505(b)(2) Approval Read Post »
This article was originally published by Li Du in BMC Medical Ethics 2018 19:29 under a creative commons license. Abstract
Patenting human genes: Chinese academic articles’ portrayal of gene patents Read Post »
Drug development is one of the world’s most high-risk / high-reward industries, with the vast majority of drugs created never
The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advantages Read Post »
Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities Make Better Decisions answers the following questions
Pharmaceutical Portfolio Management Reading List Read Post »
Artificial intelligence (AI) is the development within computer systems of the ability to perform tasks that have traditionally required human
How Artificial Intelligence Will Affect Healthcare and Drug Prices Read Post »
This paper was originally published by Dibyendu Dana, Satishkumar V. Gadhiya, Luce G. St. Surin, David Li, Farha Naaz, Quaisar Ali,
Deep Learning in Drug Discovery and Medicine – Scratching the Surface Read Post »
This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US
FDA Approval of New Drugs One of Many Goals for Drug Manufacturers Read Post »
Get fresh news and insights, drug patent expirations & more…
